InvestorsHub Logo
Followers 10
Posts 478
Boards Moderated 0
Alias Born 02/10/2006

Re: None

Tuesday, 07/05/2011 10:19:13 AM

Tuesday, July 05, 2011 10:19:13 AM

Post# of 430

Everolimus (Afinitor®) is shaping up to be a pipeline in a single drug. If I'm not mistaken it is currently approved for 4 indications. Breast cancer looks to be far and away the largest indication yet. This from a drug with a pathway (mTor)that analysts initially indicated would not amount to anything significant.

http://www.novartis.com/newsroom/media-releases/en/2011/1528340.shtml


FL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVS News